SpineCor® is a new breakthrough treatment for idiopathic scoliosis utilising a dynamic corrective brace (DCB), clinical assistant diagnostic software (SAS) and postural measurement equipment (Freepoint). In worldwide clinical use, this new treatment has been shown to be effective in 89% of cases (either by stabilisation or improvement in (Cobb) angle of the curve). The SpineCor® treatment approach is completely different to that of traditional 3-point pressure rigid braces; it is the first and only true dynamic bracing system for idiopathic scoliosis. SpineCor®’s unique approach to treatment by global postural re-education has been shown to give progressive correction over time which, unlike any previous brace treatment, is extremely stable post brace weaning. Clinical experience to date also shows better compliance and cosmetic results. SpineCor®:

• Allows patients four hours per day out of brace
• Allows total freedom of movement
• Offers better cosmesis under clothing, and
• Is cooler to wear.

With all of these benefits, it is not difficult to see why compliance might be better than with bulky, rigid braces that severely restrict movement and must be worn 23 hours per day. Although to date no specific study has been undertaken to quantify cosmetic improvement, subjectively, some striking improvements have been observed clinically. Additionally, some very positive postural changes have been noted in cases where there has been no change in Cobb angle. Summary SpineCor® offers:

• A much more acceptable treatment to patients, being cooler to wear, less restrictive, more easily concealed under clothing and 4 hours of out of brace time per day.
• No side effects. Rigid braces cause muscle atrophy and can be harmful to normal development in a growing child.
• Excellent treatment results, particularly when treatment is started early.
• Excellent stability of treatment results post bracing.
• Neuromuscular integration for maintenance of improved posture.
• Potential to reduce incidence of surgical intervention.

Conclusion SpineCor® is a highly effective for the early treatment of idiopathic scoliosis as demonstrated in the case study and also offers significant benefits to patients who present late. The real challenge is, therefore, to increase awareness of the absolute importance of early diagnosis and, that a viable treatment for early intervention is now available.